BE BIOPHARMA Trademark

Trademark Overview

On Tuesday, October 20, 2020, a trademark application was filed for BE BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the BE BIOPHARMA trademark a serial number of 90266707. The federal status of this trademark filing is REGISTERED as of Tuesday, March 25, 2025. This trademark is owned by Pulsar Biopharma, Inc.. The BE BIOPHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for diseases and disorders of the immune system; pharmaceutical preparations for the treatment of rare diseases
be biopharma

General Information

Serial Number90266707
Word MarkBE BIOPHARMA
Filing DateTuesday, October 20, 2020
Status700 - REGISTERED
Status DateTuesday, March 25, 2025
Registration Number7739341
Registration DateTuesday, March 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for diseases and disorders of the immune system; pharmaceutical preparations for the treatment of rare diseases
NOT AVAILABLE"BIOPHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code005
First Use Anywhere DateTuesday, December 17, 2024
First Use In Commerce DateTuesday, December 17, 2024

Trademark Owner History

Party NameBE BIOPHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameBE BIOPHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameBE BIOPHARMA, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139
Party NamePulsar Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02199

Trademark Events

Event DateEvent Description
Friday, October 23, 2020NEW APPLICATION ENTERED
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 19, 2021ASSIGNED TO EXAMINER
Friday, March 26, 2021NON-FINAL ACTION WRITTEN
Friday, March 26, 2021NON-FINAL ACTION E-MAILED
Friday, March 26, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 30, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, September 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 24, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 2, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 2, 2022SOU EXTENSION 1 FILED
Thursday, June 2, 2022SOU EXTENSION 1 GRANTED
Saturday, June 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 2 FILED
Tuesday, December 13, 2022SOU EXTENSION 2 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 3, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 3, 2023SOU EXTENSION 3 FILED
Wednesday, May 3, 2023SOU EXTENSION 3 GRANTED
Friday, May 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU EXTENSION 4 FILED
Wednesday, November 29, 2023SOU EXTENSION 4 GRANTED
Thursday, November 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 3, 2024SOU EXTENSION 5 GRANTED
Monday, June 3, 2024SOU EXTENSION 5 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2024USE AMENDMENT FILED
Thursday, December 19, 2024TEAS STATEMENT OF USE RECEIVED
Monday, March 3, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, March 3, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, March 3, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, March 3, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

biopharma preparations pharmaceutical diseases treatment rare system immune namely disorders immunomodulators